You are here

Clinical Trials: Digestive System Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, December 9, 2019 - 12:00
Condition:   Anal Fistula
Intervention:   Drug: E-CEL UVEC
Sponsors:   Weill Medical College of Cornell University;   Angiocrine Bioscience
Posted: Thursday, September 12, 2019 - 12:00
Condition:   Liver Cirrhosis
Intervention:   Drug: GXHPC1
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Posted: Thursday, August 29, 2019 - 12:00
Conditions:   Crohn's Disease;   Fistula;   Anal Fistula;   Pouch, Ileal;   Pouches, Ileoanal
Intervention:   Drug: mesenchymal stem cells (MSCs)
Sponsor:   The Cleveland Clinic
Not yet recruiting
Posted: Monday, July 8, 2019 - 12:00
Condition:   Crohn Disease
Interventions:   Combination Product: local co-administration of autologous ADIpose;   Other: placebo
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting
Posted: Monday, May 27, 2019 - 12:00
Condition:   NASH - Nonalcoholic Steatohepatitis
Intervention:   Drug: HepaStem
Sponsor:   Promethera Biosciences
Posted: Tuesday, May 21, 2019 - 12:00
Condition:   Liver Cirrhosis
Interventions:   Biological: 2 times SHED group;   Biological: 4 times SHED group
Sponsors:   Changhai Hospital;   Eastern Hepatobiliary Surgery Hospital;   CAR-T (Shanghai) Biotechnology Co., Ltd.
Not yet recruiting
Posted: Friday, May 10, 2019 - 12:00
Condition:   Decompensated Liver Cirrhosis
Interventions:   Biological: umbilical cord-derived mesenchymal stem cell;   Other: Comprehensive treatment
Sponsor:   Beijing 302 Hospital
Posted: Friday, April 12, 2019 - 12:00
Condition:   Perianal Fistula
Intervention:   Procedure: Lipogems
Sponsor:   Azienda Ospedaliero, Universitaria Pisana
Posted: Wednesday, April 3, 2019 - 12:00
Condition:   Efficacy and Safety
Intervention:   Biological: Mesenchymal Stromal Cells
Sponsors:   University Hospital of Liege;   Laboratoire de Thérapie Cellulaire et Génétique from CHU de Liège
Posted: Friday, March 1, 2019 - 12:00
Condition:   Acute-On-Chronic Liver Failure
Intervention:   Biological: allo-APZ2-ACLF
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   Ticeba GmbH
Not yet recruiting